Edwards Lifesciences's market cap is currently ―. The company's EPS TTM is CHF2.066; its P/E ratio is ―; Edwards Lifesciences is scheduled to report earnings on April 25, 2024, and the estimated EPS forecast is CHF0.59. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 1.53B	$ 1.48B	$ 1.53B	$ 1.46B	$ 1.35B
Gross Profit	$ 1.18B	$ 1.13B	$ 1.19B	$ 1.13B	$ 1.09B
EBIT	$ 452.20M	$ 424.20M	$ 329.40M	$ 398.60M	$ 451.40M
EBITDA	$ 496.40M	$ 468.10M	$ 372.40M	$ 440.60M	-
Net Income Common Stockholders	$ 369.90M	$ 384.90M	$ 307.10M	$ 340.50M	$ 398.40M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.64B	$ 1.86B	$ 1.51B	$ 1.25B	$ 1.22B
Total Assets	$ 9.36B	$ 9.37B	$ 9.00B	$ 8.65B	$ 8.29B
Total Debt	$ 694.90M	$ 691.10M	$ 684.50M	$ 687.80M	$ 691.30M
Net Debt	$ -949.60M	$ -1.17B	$ -824.80M	$ -566.40M	$ -524.00M
Total Liabilities	$ 2.64B	$ 2.64B	$ 2.44B	$ 2.59B	$ 8.55B
Stockholders Equity	$ 6.65B	$ 6.66B	$ 6.49B	$ 5.98B	$ 6.20B
Cash Flow	-
Free Cash Flow	$ 8.80M	$ 356.20M	$ 12.60M	$ 251.90M	$ 140.90M
Operating Cash Flow	$ 110.40M	$ 411.50M	$ 60.50M	$ 313.40M	$ 230.00M
Investing Cash Flow	$ 40.30M	$ 89.00M	$ 43.30M	$ 1.20M	$ 147.50M
Financing Cash Flow	$ -413.20M	$ -143.30M	$ 52.10M	$ -206.60M	$ -838.40M

Currency in USD

Edwards Lifesciences Earnings and Revenue History

Income Statement >

Edwards Lifesciences Debt to Assets

Balance Sheet >

Edwards Lifesciences Cash Flow

Cash Flow >

Edwards Lifesciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing